Signature Series: Unlocking the Potential of Device-Based Hypertension Therapies and Partnerships — 1 on 1 with David Hochman and Chris Eso | LSI USA '25

This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA.

Join moderator David Hochman (Orchestra BioMed, Inc.) and speaker Chris Eso (Medtronic) as they discuss groundbreaking innovations and strategic partnerships reshaping cardiac pacing, device-based hypertension therapies, and risk-reward sharing models in medtech.

This panel featured:

David Hochman — Orchestra BioMed, Inc.

Chris Eso — Medtronic

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

Follow us on social!

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw